Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

CIK 0001757499 · Healthcare · Drug Manufacturers

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q1-2026 —
Latest FY-2025 8-K (2026-02-17)
Q3-2025 —
Q2-2025 —
Q1-2025 —
FY-2024 8-K (2025-02-26)
Q3-2024 8-K (2024-11-13) · 99.1
Q1-2024
Q2-2024 8-K (2024-05-14) · 99.1
FY-2023
Q1-2024 8-K (2024-03-22) · 99.1
FY-2023 8-K (2023-11-14) · 99.1
Q3-2023 8-K (2023-08-15) · 99.1
Q2-2023 8-K (2023-05-26) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Operations
Condensed Consolidated Statements of Changes In Stockholders' Equity (deficit) (unaudited)
—
Consolidated Statements of Changes In Stockholders' Equity
Condensed Consolidated Statements of Changes In Stockholders' Equity (deficit) (unaudited) (P)
—
Consolidated Statements of Changes In Stockholders' Equity (P)
Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows (P)
Notes
Business Segment Information
Commitments and Contingencies
Convertible Notes
Convertible Notes and Loan Agreement
Convertible Notes and Notes Payable
—
Cybersecurity Risk Management and Strategy Disclosure
—
Derivative Liabilities
Income Taxes
—
Insider Trading Arrangements
Leases
Manufacturing Agreement
—
Molecule.ai Asset Acquisition
Net Loss Per Share
—
Notes Payable-related Party
Organization and Liquidity
Other Related Party Transactions
—
Pay Vs Performance Disclosure
Related Party Transactions
Stockholders Equity
Subsequent Events
Summary of Significant Accounting Policies